Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19

novavax

These WHO interim recommendations on the use of the Novavax NVX-CoV2373 vaccine against COVID-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE).

Additional information: